The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-treatment circulating tumor DNA as a biomarker for disease burden in diffuse large B cell lymphoma (DLBCL).
 
Florian Scherer
No Relationships to Disclose
 
David Matthew Kurtz
No Relationships to Disclose
 
Michael Richard Green
No Relationships to Disclose
 
Aaron M. Newman
No Relationships to Disclose
 
Daniel M. Klass
No Relationships to Disclose
 
Li Zhou
No Relationships to Disclose
 
Rashi Krishnan
No Relationships to Disclose
 
Chih Long Liu
No Relationships to Disclose
 
Cynthia Glover
No Relationships to Disclose
 
Robert S. Ohgami
No Relationships to Disclose
 
Rodney J Hicks
No Relationships to Disclose
 
Colm Keane
No Relationships to Disclose
 
Katherine A Kong
Employment - Sequenta
 
Malek Faham
Leadership - Sequenta
Stock and Other Ownership Interests - Sequenta
 
Mark S. Hertzberg
No Relationships to Disclose
 
Maher K Gandhi
No Relationships to Disclose
 
Ranjana H. Advani
Honoraria - Eisai; GE Healthcare; Millennium
Research Funding - Agensys (Inst); Allos Therapeutics (Inst); Celgene (Inst); Genentech/Roche (Inst); Idera (Inst); Janssen (Inst); Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genentech; Seagen
 
Ronald Levy
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - BeiGene; Bullet Bio; Five Prime Therapeutics; ImmunoCellular Therapeutics; Inate Pharma; Kite, a Gilead company
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline
 
Maximilian Diehn
Stock and Other Ownership Interests - Roche
Consulting or Advisory Role - Quanticel Pharma
Research Funding - Varian Medical Systems
 
Ash A. Alizadeh
Stock and Other Ownership Interests - Roche
Honoraria - Roche
Consulting or Advisory Role - Celgene; Roche/Genentech
Research Funding - Celgene